Methadone, Pierre Robin sequence and other congenital anomalies: case–control study

Objective Methadone is a vital treatment for women with opioid use disorder in pregnancy. Previous reports suggested an association between methadone exposure and Pierre Robin sequence (PRS), a rare craniofacial anomaly. We assessed the association between gestational methadone exposure and PRS. Design/setting This case-malformed control study used European Surveillance of Congenital Anomalies population-based registries in Ireland, the Netherlands, Italy, Switzerland, Croatia, Malta, Portugal, Germany, Wales, Norway and Spain, 1995–2011. Patients Cases included PRS based on International Classification of Disease (ICD), Ninth Edition-British Paediatric Association (BPA) code 75 603 or ICD, Tenth Edition-BPA code Q8708. Malformed controls were all non-PRS anomalies, excluding genetic conditions, among live births, fetal deaths from 20 weeks’ gestation and terminations of pregnancy for fetal anomalies. An exploratory analysis assessed the association between methadone exposure and other congenital anomalies (CAs) excluding PRS. Methadone exposure was ascertained from medical records and maternal interview. Results Among 87 979 CA registrations, there were 127 methadone-exposed pregnancies and 336 PRS cases. There was an association between methadone exposure and PRS (OR adjusted for registry 12.3, 95% CI 5.7 to 26.8). In absolute terms, this association reflects a risk increase from approximately 1–12 cases per 10 000 births. A raised OR was found for cleft palate (adjusted OR 5.0, 95% CI 2.7 to 9.2). Conclusions These findings suggest that gestational methadone exposure is associated with PRS. The association may be explained by unmeasured confounding factors. The small increased risk of PRS in itself does not alter the risk–benefit balance for gestational methadone use. The association with cleft palate, a more common CA, should be assessed with independent data.

[1]  F. Mehendale,et al.  Epidemiology of Robin sequence with cleft palate in the East of Scotland between 2004 and 2013 , 2018, Pediatric pulmonology.

[2]  Meghan T. Frey,et al.  Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review , 2017, Pediatrics.

[3]  Inna Chervoneva,et al.  Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome , 2017, The New England journal of medicine.

[4]  S. Bing,et al.  Maternal active smoking and risk of oral clefts: a meta-analysis. , 2016, Oral surgery, oral medicine, oral pathology and oral radiology.

[5]  M. Terplan,et al.  Detoxification from opiates during pregnancy: stressing the fetal brain. , 2016, American journal of obstetrics and gynecology.

[6]  H. Dolk,et al.  Response to: Case–control studies require appropriate population controls: an example of error in the SSRI birth defect literature , 2015, European Journal of Epidemiology.

[7]  Thomas R Frieden,et al.  Medication-assisted therapies--tackling the opioid-overdose epidemic. , 2014, The New England journal of medicine.

[8]  C. Poets,et al.  Birth prevalence and initial treatment of Robin sequence in Germany: a prospective epidemiologic study , 2014, Orphanet Journal of Rare Diseases.

[9]  T. Fahey,et al.  Methadone and perinatal outcomes: a prospective cohort study. , 2012, Addiction.

[10]  Marie J. Hayes,et al.  Epidemic of prescription opiate abuse and neonatal abstinence. , 2012, JAMA.

[11]  M. Cunningham,et al.  Robin Sequence: From Diagnosis to Development of an Effective Management Plan , 2011, Pediatrics.

[12]  M. Loane,et al.  Paper 5: Surveillance of multiple congenital anomalies: implementation of a computer algorithm in European registers for classification of cases. , 2011, Birth defects research. Part A, Clinical and molecular teratology.

[13]  David Tucker,et al.  Paper 6: EUROCAT member registries: organization and activities. , 2011, Birth defects research. Part A, Clinical and molecular teratology.

[14]  T. Fahey,et al.  Methadone and perinatal outcomes: a retrospective cohort study. , 2011, American journal of obstetrics and gynecology.

[15]  H. Jones,et al.  Neonatal abstinence syndrome after methadone or buprenorphine exposure. , 2010, The New England journal of medicine.

[16]  M. Loane,et al.  Valproic acid monotherapy in pregnancy and major congenital malformations. , 2010, The New England journal of medicine.

[17]  E. Ravndal,et al.  Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study. , 2010, Drug and alcohol dependence.

[18]  D. Courtemanche,et al.  Robin sequence: clearing nosologic confusion. , 2010, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[19]  G. Bury,et al.  Prevalence of problem alcohol use among patients attending primary care for methadone treatment , 2009, BMC Family Practice.

[20]  A. Munnich,et al.  Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence , 2009, Nature Genetics.

[21]  M. Werler,et al.  Maternal Periconceptional Illicit Drug Use and the Risk of Congenital Malformations , 2009, Epidemiology.

[22]  H. Jones,et al.  Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. , 2008, The American journal on addictions.

[23]  M. Loane,et al.  Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? , 2008, Neurology.

[24]  S. Rasmussen,et al.  Maternal Smoking and Environmental Tobacco Smoke Exposure and the Risk of Orofacial Clefts , 2007, Epidemiology.

[25]  N. Tommerup,et al.  The Genetic Basis of the Pierre Robin Sequence , 2006, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[26]  H. Dolk.  EUROCAT: 25 years of European surveillance of congenital anomalies , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[27]  Mikael Andersen,et al.  Pierre Robin Sequence in Denmark: A Retrospective Population-Based Epidemiological Study , 2004, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[28]  A. Munnich,et al.  Pierre Robin sequence: a series of 117 consecutive cases. , 2001, The Journal of pediatrics.

[29]  E. Hook.  What kind of controls to use in case control studies of malformed infants: recall bias versus "teratogen nonspecificity" bias. , 2000, Teratology.

[30]  T. Einarson,et al.  Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies , 1998, BMJ.

[31]  L. Finnegan,et al.  Opioid dependence during pregnancy. Effects and management. , 1998, Obstetrics and gynecology clinics of North America.

[32]  Thomas Db,et al.  Cleft palate, mortality and morbidity in infants of substance abusing mothers , 1995, Journal of paediatrics and child health.

[33]  R. Shprintzen.  The implications of the diagnosis of Robin sequence. , 1992, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[34]  Bracken Mb,et al.  Exposure to prescribed drugs in pregnancy and association with congenital malformations. , 1981 .

[35]  T R Holford,et al.  Exposure to Prescribed Drugs in Pregnancy and Association with Congenital Malformations , 1981, Obstetrics and gynecology.

[36]  A. Eidelman,et al.  Differential effects of maternal heroin and methadone use on birthweight. , 1976, Pediatrics.

[37]  I. Saxén.  Associations between oral clefts and drugs taken during pregnancy. , 1975, International journal of epidemiology.

[38]  L. Finnegan,et al.  Prenatal narcotic exposure: perinatal and developmental effects. , 1989, Neurotoxicology.